loratadine has been researched along with ambroxol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Alcántar, F; Herrera, J; Morales, JM; RodrĂguez, JM; Rosete, R; Villacampa, J | 1 |
1 trial(s) available for loratadine and ambroxol
Article | Year |
---|---|
Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men.
Topics: Administration, Oral; Adolescent; Adult; Ambroxol; Area Under Curve; Cross-Over Studies; Drug Combinations; Expectorants; Histamine Antagonists; Humans; Loratadine; Male; Middle Aged; Piperidines; Pyridines; Tablets; Time Factors | 2003 |
2 other study(ies) available for loratadine and ambroxol
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |